| Document |
Document Title |
|
WO/2023/235189A1 |
This invention discloses a poly (hexafluoropropylene oxide) (HFPO) mixture that contains a bifunctional and a monofunctional poly (HFPO) component. A process utilizing liquid or supercritical fluid chromatography may be used to separate ...
|
|
WO/2023/223924A1 |
Provided is a compound that, although a curable resin, is able to to easily achieve repairability and reformability in a cured object. Also provided is a curable resin composition using the same, and a cured object thereof. The present i...
|
|
WO/2023/223923A1 |
Provided are: a compound which, while being a curable resin, can easily exhibit recoverability/re-moldability when being in the form of a cured product; a curable resin composition obtained using same; and a cured product thereof. Used i...
|
|
WO/2023/211710A1 |
Disclosed herein are aspects of a method for producing hydrogen peroxide. The method may comprise exposing a substrate to light in the presence of an organic photocatalyst and oxygen, and optionally a photosensitizer to produce an oxidat...
|
|
WO/2023/187302A1 |
The invention relates to the use of a composition comprising at least one derivative compound which is derived from cashew nut shell oil (CNSL) and which has at least one ester function and/or at least one epoxide function, as a plastici...
|
|
WO/2023/182141A1 |
Provided is a glycidyl amine-type fluorine-containing epoxy compound. The present disclosure relates to a fluorine-containing epoxy compound represented by general formula (1). In general formula (1), n each independently represents an i...
|
|
WO/2023/181926A1 |
One embodiment of the present invention provides a method for purifying a (meth)acrylic acid monomer and/or a (meth)acrylic acid ester monomer, the method comprising purification of a composition that contains a (meth)acrylic acid monome...
|
|
WO/2023/182522A1 |
The present invention provides an epoxy resin which has a skeleton represented by formula (1). In formula (1), each of R4 and R5 independently represents a hydrogen atom, an alkoxy group or -OG; * may be a binding site to be bonded with ...
|
|
WO/2023/173812A1 |
Provided are an α-alumina support, an α-alumina-based catalyst, a preparation method therefor and an application thereof. The preparation method comprises the following steps: (1) mixing a silicon-modified fiber material, hydrated alum...
|
|
WO/2023/160593A1 |
Provided in the present invention are a physically mixed catalyst for the epoxidation of propylene using hydrogen and oxygen, and a preparation method therefor. The catalyst is prepared by loading gold on a carrier which contains no tita...
|
|
WO/2023/162693A1 |
Provided are: an epoxy resin which is useful as an insulating material for electrical/electronic components, exhibits excellent handleability as a solid at ordinary temperatures, has a low viscosity at the time of molding, and exhibits e...
|
|
WO/2023/156996A1 |
The invention provides novel inhibitors of MetAp2 enzymatic activity and uses thereof.
|
|
WO/2023/153160A1 |
Provided are: a phenolic resin having a specific structure used to obtain an epoxy resin having low viscosity and excellent handling properties, or the epoxy resin that can be used to obtain a cured product having low water absorption an...
|
|
WO/2023/143988A1 |
The present invention relates to a compound of formula (I) wherein X is selected from the group consisting of oxo, sulfanyl and hydroxy, and if X is hydroxy, the stereocenter in position (3) is in S configuration; R1 is selected from the...
|
|
WO/2023/142618A1 |
Provided is a synthesis method for Euphorbia diterpenoid Pepluanol A. By using a cycloheptenone derivative as a reaction raw material, a key tricyclic skeleton is constructed by means of key steps such as a Negishi coupling reaction, a D...
|
|
WO/2023/135480A1 |
The present invention relates to new cathepsin B inhibitors, which are effective in therapy, and in particular in the treatment of diseases associated with an impaired activity of the β-galactosidase, such as GM-1 gangliosidosis, Morqui...
|
|
WO/2023/126369A1 |
The present invention relates to an alkoxylated cycloaliphatic epoxide according to the following formula (I) wherein each R1 and R2 is independently selected from H and Me; L is the residue of a polyol; each a is independently from 2 to...
|
|
WO/2023/117844A1 |
The invention relates to a compound of the following formula (I) and to a synthesis method thereof, wherein: - T represents a chemical group selected from the group consisting of -CHO, -CH=NOH and -CN+-O-; - R1 represents a chemical grou...
|
|
WO/2023/115123A1 |
Provided herein is a crystalline intermediate useful in the manufacture of 6,7-epoxytigliane compounds. Methods of making the 6,7-epoxytigliane compounds using the crystalline intermediates are also provided, as well as high purity 6,7-e...
|
|
WO/2023/114821A1 |
The disclosure relates to a plasticizer composition comprising an epoxidized fatty acid C1-C6 alkyl ester component wherein the epoxidized fatty acid C1-C6 alkyl ester component contains (i) less than 6% saturated fatty acid residues and...
|
|
WO/2023/100722A1 |
Provided is an epoxy resin from which a cured product exhibiting excellent dielectric characteristics and also having favorable mechanical characteristics is obtained. The epoxy resin is characterized by having a structure represented by...
|
|
WO/2023/096904A2 |
Provided herein are compound of Formula (I) and (II), and pharmaceutically acceptable salts thereof. Also provided are methods of preparing the compounds, pharmaceutically acceptable compositions thereof, and methods of their use and tre...
|
|
WO/2023/089228A1 |
The present disclosure relates to a process for epoxidizing an olefin mixture (11), comprising at least two olefins selected from the group consisting of ethylene, propylene and 1-butylene. Particularly the present disclosure relates to ...
|
|
WO/2023/068933A1 |
In accordance with the present invention there is provided a process for the production of organic compounds with at least one oxygen atom in their structure, which process comprises the steps of: - feeding a first stream comprising CO2 ...
|
|
WO/2023/060955A1 |
Provided in the present invention is a synthetic method for cetyl-PG hydroxyethyl palmitamide. The method comprises the following steps: firstly, mixing 1,3-dichloropropanol and hexadecyl alcohol under the action of a catalyst and an alk...
|
|
WO/2023/061999A1 |
The present invention discloses a distinct mode of action of a nickel catalyst to forge C-0 bonds to unlock the mild utilization of N2O as O-atom transfer reagent in the synthesis of complex phenols from the corresponding aryl halides.
|
|
WO/2023/058449A1 |
Provided are: a naphthalene dithiol capable of achieving both high refractive index and high solubility (compatibility) or a derivative thereof; and a production method and a use for the same. A naphthalene compound according to the pr...
|
|
WO/2023/051747A1 |
A lubricity improver and an application thereof. The lubricity improver comprises a compound having a structure shown in formula (I), groups R1 and R2 each independently being a single bond or a substituted or unsubstituted C1-C20 alkyle...
|
|
WO/2023/032820A1 |
Provided are: a resin composition including at least one resin selected from the group consisting of cyclized resins and precursors thereof, and a compound B, which has a ring opening-polymerizable group, also has at least one structure ...
|
|
WO/2023/025861A1 |
The present invention concerns a compound of formula (I) or a pharmaceutically acceptable salt and/or solvate thereof, wherein X, R1, R2, R3 are defined, a conjugate thereof and their uses as drug or research tools.
|
|
WO/2023/019663A1 |
The present invention relates to the field of biological control of tea garden pests Ectropis obliqua and Ectropis grisescens warren, and provides an efficient compound lure for Ectropis obliqua and Ectropis grisescens warren. (3Z,6Z,9Z)...
|
|
WO/2023/009610A1 |
The application discloses methods useful for the synthesis of racemic, scalemic, and chiral alpha-tocotrienol quinone, including synthetic intermediates and methods for making said synthetic intermediates.
|
|
WO/2023/272571A1 |
A compound as represented by formula 1 that has an inhibitory effect on the novel coronavirus 2019-nCoV; a racemate or an optical isomer thereof, a solvate thereof, or a pharmaceutically acceptable salt thereof; and the use thereof in th...
|
|
WO/2023/275324A1 |
The present invention relates to a process for preparing at least one schweinfurthin chosen from schweinfurthin G of formula (SW-G), schweinfurthin K of formula (SW-K) and schweinfurthin R of formula (SW-R), characterized in that it comp...
|
|
WO/2022/268840A1 |
Described herein are methods for making intermediates in the production of fragrance ingredients starting from β-farnesene. In particular, methods for making acetylmethylfarnesol and hydroxy-farnesylacetone are described. Methods for ma...
|
|
WO/2022/267081A1 |
Disclosed is a green and efficient method for catalyzing butene to prepare epoxybutane with organic small molecules. The method uses butene as a raw material, an organic solvent and a catalyst are added, isobutyraldehyde is used as a co-...
|
|
WO/2022/263437A1 |
In a first aspect, the present invention relates to a shutdown method for a process for preparing an olefin oxide comprising a normal run stage, wherein the normal run stage comprises providing olefin, hydrogen peroxide and organic solve...
|
|
WO/2022/238145A1 |
The integrated plant for making propene oxide comprises a unit (1) for producing hydrogen peroxide by an anthraquinone process, which comprises a hydrogenator (3), an oxidizer (4) and an extraction column, and a unit (2) for making prope...
|
|
WO/2022/230745A1 |
The present invention provides a compound which is represented by formula (1). (In formula (1), each of R1, R2, R3 and R4 independently represents a hydrogen atom, a polymerizable functional group having 1 to 50 carbon atoms or an alkyl ...
|
|
WO/2022/231172A1 |
The present invention relates to: a multifunctional epoxy compound obtained by modifying two or more epoxide functional groups on terminal portions of liquid crystal molecules synthesized by bonding multiple thermotropic liquid crystal m...
|
|
WO/2022/224820A1 |
The present invention provides: a compound represented by formula I, formula I', formula II, or formula II'; and a composition that is for regulating circadian rhythm and that contains said compound or an Agrocybe erebia culture.
|
|
WO/2022/213996A1 |
Disclosed is a compound comprising at least one structural unit represented by formulas (1)-(4). The compound comprises at least one cross-linkable group. The compound has a relatively large molar extinction coefficient and high fluoresc...
|
|
WO/2022/210324A1 |
Provided are: a resin composition including a precursor of a cyclized resin and a base generator, wherein the base generated by the base generator is a base that cyclizes within the same molecule and becomes a tertiary amine, and the bas...
|
|
WO/2022/189559A1 |
The present invention relates to a process for preparing an olefin oxide from a reaction mixture stream in an epoxidation reactor R, wherein R contains z active reaction tubes T(i) arranged in parallel, z≥2, i=1...z, wherein each T(i) ...
|
|
WO/2022/158462A1 |
Provided are a glycidyl (meth)acrylate composition wherein a phenolic polymerization inhibitor included therein does not readily deteriorate and the glycidyl (meth)acrylate composition can be stably preserved for a long time period, as w...
|
|
WO/2022/158463A1 |
The present invention provides: a glycidyl (meth)acrylate composition that can be stably stored for long periods of time without a phenolic polymerization inhibitor that is included in the composition being readily degraded; and a method...
|
|
WO/2022/155779A1 |
A preparation process for epichlorohydrin. The process involves the following steps: (1) a chlorination reaction, wherein glycerol and hydrogen chloride gas are transported to a reaction kettle for a chlorination reaction; and (2) a cycl...
|
|
WO/2022/149468A1 |
Provided is a bisphenol AF-type diglycidyl ether represented by formula (1), wherein an abundance ratio of the bisphenol AF-type diglycidyl ether having n≥1 is less than 30 mass%. (In formula (1), R1-R8 are each independently a hydroge...
|
|
WO/2022/148456A1 |
Pharmaceutical compositions comprising a chemotherapeutic agent based on a β-substituted β-amino acid derivative are disclosed. The pharmaceutical compositions include a β-substituted β-amino acid derivative and a cyclodextrin deriva...
|
|
WO/2022/133544A1 |
Cannabidiol (CBD) cannabinoids and CBD cannabinoid analogues with, inter alia, antimicrobial activity, synthetic methods for the preparation thereof and medical uses and formulations containing same.
|
